Nuzenio

Immuno

Immuno news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 09:14:00 GMTSenhwa's CX-5461 Reaches Immuno-Oncology Milestone as its First Multicenter Combination Trial with PD-1 Inhibitor Receives TFDA Clearance - PR Newswire
Wed, 05 Aug 2026 18:39:42 GMTCelebrating 41 Years of Immuno-Oncology Innovation - Society for Immunotherapy of Cancer - Oncodaily
Mon, 03 Aug 2026 18:20:56 GMTThe Future of Immuno-Oncology Clinical Trial Design – SITC - Oncodaily
Mon, 03 Aug 2026 11:05:30 GMTCGEN: AI-driven immuno-oncology pipeline advances with key AstraZeneca and Gilead partnerships - TradingView
Sun, 02 Aug 2026 22:27:24 GMTAACR Immuno-Oncology 2027 - Oncodaily
Tue, 28 Jul 2026 15:44:16 GMTImmuno 2026: Global Virtual Congress on Immuno Oncology - Oncodaily

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Immuno.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.